Skip to content
Biodatica
Start free

Investigator

Suchismita Acharya

AYUVIS RESEARCH, INC. · funded by NICHD

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$1.1M

Summed across those awards.

First award
Apr 12, 2024

On this record.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates

    $712k

    Apr 12, 2024NICHDAYUVIS RESEARCH, INC.NIH RePORTER · 11074691 (opens the source filing in a new tab)

  2. R44

    Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates

    $360k

    Apr 12, 2024NICHDAYUVIS RESEARCH, INC.NIH RePORTER · 11309117 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources